Clinical Trial

"The Effect of The Combination Therapy of Statin and SGLT2i in The Treatment of Ischemic Heart Disease"

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 11, 2025 (before its estimated November 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
correlate the serum level of statin and SGLT2i when given as polytherapy with HPLC in ischemic heart failure patients and their laboratory tests (cholesterol, LDL, HDL and TG...)
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-07-20; most recent amendment 2025-09-10.
Trial Details
NCT Number NCT06520891
Lead Sponsor Fayoum University
Conditions 2 Drugs Are Statin and SGLT2i
Enrollment 90 participants
Start Date 2024-06-01
Primary Completion 2025-11-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-09-11